0000000000418616
AUTHOR
G. Rudolf
Neutron capture cross section measurements for nuclear astrophyisics at CERN n_TOF
A series of neutron capture cross section measurements of interest to nuclear astrophysics have been recently performed at n_TOF, the neutron spallation source operating at CERN. The low repetition frequency of the proton beam driver, the extremely high instantaneous neutron flux, and the low background conditions in the experimental area are optimal for capture cross section measurements on low-mass or radioactive samples. An overview of the measurements performed during the two experimental campaigns in 2002 and 2003 is presented with special emphasis on the measurement of the capture cross sections of the Os isotopes relevant for the cosmochronology based on the Re/Os clock. http://www.s…
Neutron measurements for advanced nuclear systems: The n_TOF project at CERN
A few years ago, the neutron time-of-flight facility n_TOF was built at CERN to address some of the urgent needs of high-accuracy nuclear data for Accelerator Driven Systems and other advanced nuclear energy systems, as well as for nuclear astrophysics and fundamental nuclear physics. Thanks to the characteristics of the neutron beam, and to state-of-the-art detection and acquisition systems, high quality neutron cross-section data have been obtained for a variety of isotopes, many of which radioactive. Following an important upgrade of the spallation target and of the experimental area, a new measurement campaign has started last year. After a brief review of the most important results obt…
Neutron cross section measurements at n_TOF for ADS related estudies
A neutron Time-of-Flight facility (n_TOF) is available at CERN since 2001. The innovative features of the neutron beam, in particular the high instantaneous flux, the wide energy range, the high resolution and the low background, make this facility unique for measurements of neutron induced reactions relevant to the field of Emerging Nuclear Technologies, as well as to Nuclear Astrophysics and Fundamental Nuclear Physics. The scientific motivations that have led to the construction of this new facility are here presented. The main characteristics of the n_TOF neutron beam are described, together with the features of the experimental apparata used for cross-section measurements. The main res…
Measurement of the n-TOF beam profile with a micromegas detector
A Micromegas detector was used in the neutron Time-Of-Flight (n_TOF) facility at CERN to evaluate the spatial distribution of the neutron beam as a function of its kinetic energy. This was achieved over a large range of neutron energies by using two complementary processes: at low energy by capture of a neutron via the 6Li(n,[alpha])t reaction, and at high energy by elastic scattering of neutrons on gas nuclei (argon+isobutane or helium+isobutane). Data are compared to Monte Carlo simulations and an analytic function fitting the beam profile has been calculated with a sufficient precision to use in neutron capture experiments at the n_TOF facility. http://www.sciencedirect.com/science/artic…
Type-I interferons are potent inhibitors of interleukin-8 production in hematopoietic and bone marrow stromal cells
Abstract nterleukin-8 (IL-8) is produced by many cell types upon stimulation with bacterial products or inflammation-associated cytokines such as tumor necrosis factor-alpha and IL-1. Interferons (IFNs) represent another group of cytokines that are induced by similar stimuli in inflammatory reactions. We show now that type-I IFNs are potent inhibitors of IL-8 expression in vitro and in vivo. A significant reduction of both secretion of IL-8 protein and accumulation of IL-8 mRNA in vitro was observed in several cell types comprising peripheral blood mononuclear cells (PBMNC) from healthy donors and from patients with chronic myelogenous leukemia (CML), the myelomonocytic cell line THP-1, and…
Energy damping and intermediate-velocity fragment emission in peripheral Kr+Au collisions at 43 MeV/u
Abstract Triple and four-fold coincidences among fragments have been measured in the reaction 84 Kr+Au at 43 MeV/u. All events showing the projectile-like nucleus and fission fragments of the target-like nucleus, and all events with one additional intermediate-velocity fragment, were analysed in the frame of a dissipative collision and a participant-spectator model. The mechanism is basically that of a dissipative collision but the emission of the intermediate velocity fragment by the target differs from an equilibrated evaporation.
Measurement of the 151Sm n,gamma 152Sm cross section at n_TOF
The 151 Sm(n, γ ) 152 Sm cross section, which is important for the interpretation of the 151 Sm branching as an s -process thermometer, was measured from 1 eV up to 1 MeV at the innovative n_TOF facility at CERN. Based on these data, the Maxwellian-averaged cross section at k T = 30 keV is found to be 3100±160 mb. This value can be used to constrain the thermodynamical conditions in Asymptotic Giant Branch (AGB) stars during He-shell burning.
Measurements of the 90,91,92,94,96 Zr n, gamma cross-sections at n_TOF
Neutron capture cross sections of the 90,91,92,94,96Zr have been measured over the energy range from 1 eV to 1 MeV at the spallation neutron facility n TOF at CERN in 2003. The innovative features of the neutron beam, in particular the high instantaneous flux, the high energy resolution and low background, together with improvements of the neutron sensitivity of the capture detectors make this facility unique for neutron-induced reaction cross section measurements with much improved accuracy. The preliminary results of the Zr measurements show capture resonance strengths generally smaller than in previous measurements. Peer Reviewed
Divergent in vivo and in vitro antileukemic activity of recombinant interferon beta in patients with chronic-phase chronic myelogenous leukemia
It was the aim of this study to investigate the antileukemic activities of recombinant interferon beta (rIFN beta) in chronic-phase CML in vitro and in vivo. Nine patients in the early chronic-phase of CML were treated in a phase-II trial with escalating doses of rIFN beta. In parallel, antiproliferative and immunomodulatory activities of rIFN beta and rIFN alpha 2b were studied in vitro. rIFN beta exhibited a significantly higher antiproliferative activity on hematopoietic progenitor cells of CML patients in vitro than rIFN alpha 2b. In contrast, only very limited clinical antileukemic efficacy of rIFN beta was observed. None of the patients achieved a complete or partial hematologic respo…